Displaying results 97 - 108 of 158
General Hepatology
Immune landscaping in a mouse model unveils an immunosuppressive cell composition in hepatic crown-like structures involved in metabolic dysfunction-associated steatohepatitis

Immune landscaping in a mouse model unveils an immunosuppressive cell composition in hepatic crown-like structures involved in...

ePosters
View
General Hepatology
Liver stiffness measurement by SuperSonic Imagine two-dimensional shear wave elastography to predict hepatocellular carcinoma in non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Liver stiffness measurement by SuperSonic Imagine two-dimensional shear wave elastography to predict hepatocellular carcinoma ...

ePosters
View
General Hepatology
Comparative analysis of prevalence, metabolic profiles, and socio-demographic characteristics of MetALD, MASLD, and ALD in a rural area

Comparative analysis of prevalence, metabolic profiles, and socio-demographic characteristics of MetALD, MASLD, and ALD in a r...

ePosters
View
General Hepatology
Determinants of liver stiffness improvements and worsening in metabolic dysfunction associated steatotic liver disease: Insights from two cohorts

Determinants of liver stiffness improvements and worsening in metabolic dysfunction associated steatotic liver disease: Insigh...

ePosters
View
General Hepatology
Prognostic significance of ELF test compared to liver elastography and liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Prognostic significance of ELF test compared to liver elastography and liver biopsy in patients with metabolic dysfunction-ass...

ePosters
View
General Hepatology
Dynamic change in the enhanced liver fibrosis test to predict adverse outcomes in chronic liver disease

Dynamic change in the enhanced liver fibrosis test to predict adverse outcomes in chronic liver disease

ePosters
View
General Hepatology
Low doses of bacterial D-lactate modulate liver steatosis and ameliorate experimental MASLD

Low doses of bacterial D-lactate modulate liver steatosis and ameliorate experimental MASLD

ePosters
View
General Hepatology
Gaps in MAFLD screening and management: a retrospective audit of patients at cardiometabolic risk in secondary care

Gaps in MAFLD screening and management: a retrospective audit of patients at cardiometabolic risk in secondary care

ePosters
View
General Hepatology
Metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with inflammatory bowel disease (IBD): A single-center prospective study.

Metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with inflammatory bowel disease (IBD): A single-c...

ePosters
View
General Hepatology
Bone fragility and fracture risk assessment in metabolic disfunction-associated steatotic liver disease

Bone fragility and fracture risk assessment in metabolic disfunction-associated steatotic liver disease

ePosters
View
General Hepatology
Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective study

Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective stu...

ePosters
View
General Hepatology
Determining the prevalence and characterizing the associated factors and health outcomes related to Metabolic dysfunction-associated steatotic liver disease (MASLD) and Metabolic dysfunction-associated steatohepatitis (MASH) in patients with type 2 diabet

Determining the prevalence and characterizing the associated factors and health outcomes related to Metabolic dysfunction-asso...

ePosters
View
Displaying results 97 - 108 of 158